To explore the immune landscape in breast cancer, we used the ESTIMATE algorithm to assess immune scores, stromal scores, and tumor purity between the GFPT1-Low and GFPT1-High groups in BRCA (Newman et al., 2015). Here, GFPT1 is linked to neoplasm.